In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

The in vitro activity of ceftazidime in combination with NXL104 versus 470 Pseudomonas aeruginosa clinical isolates was evaluated using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods. Ceftazidime had MIC(90)s of 8 μg/ml and 32 μg/ml in the presence and absence of NXL1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Walkty, A., DeCorby, M., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2011
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101411/
https://ncbi.nlm.nih.gov/pubmed/21422208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01696-10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars